Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats

Journal of Molecular and Cellular Cardiology

Volumn 57, Issue 1, 2013, Pages 106-118

  Guleria, Rakeshwar S ^a   Singh, Amar B ^a   Nizamutdinova, Irina T ^a   Souslova, Tatiana ^b   Mohammad, Amin A ^b   Kendall, Jonathan A ^a   Baker, Kenneth M ^a   Pan, Jing ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Cardiac remodeling; Diabetic cardiomyopathy; Retinoic acid; Retinoid receptor; Type 2 diabetes; Zucker diabetic fatty rats

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; BEXAROTENE; FATTY ACID; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; ENZYME ACTIVATION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; HEART MUSCLE FIBROSIS; HYPERLIPIDEMIA; INFLAMMATION; INTRACELLULAR SIGNALING; LIPID STORAGE; MALE; METABOLIC REGULATION; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TREATMENT OUTCOME; WEIGHT GAIN;

ANIMALS; BENZOATES; BLOOD GLUCOSE; COLLAGEN; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GLUCOSE; HOMEOSTASIS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; LIPID METABOLISM; MALE; MYOCARDIUM; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, ZUCKER; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; TETRAHYDRONAPHTHALENES;

RATTUS;

EID: 84874083180     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.01.017     Document Type: Article

References (42)

1. Murarka S., Movahed M.R. Diabetic cardiomyopathy. J Card Fail Dec 2010, 16(12):971-979.
2. Feuvray D., Darmellah A. Diabetes-related metabolic perturbations in cardiac myocyte. Diabetes Metab Feb 2008, 34(Suppl. 1):S3-S9.
3. Mariappan N., Elks C.M., Sriramula S., Guggilam A., Liu Z., Borkhsenious O., et al. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res Feb 1 2010, 85(3):473-483.
4. Westermann D., Rutschow S., Van Linthout S., Linderer A., Bucker-Gartner C., Sobirey M., et al. Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia Oct 2006, 49(10):2507-2513.
5. Li C.J., Lv L., Li H., Yu D.M. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol Jun 19 2012, 11(1):73.
6. Van Y.H., Lee W.H., Ortiz S., Lee M.H., Qin H.J., Liu C.P. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes Jan 2009, 58(1):146-155.
7. Mercader J., Ribot J., Murano I., Felipe F., Cinti S., Bonet M.L., et al. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology Nov 2006, 147(11):5325-5332.
8. Amengual J., Ribot J., Bonet M.L., Palou A. Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice. Obesity (Silver Spring) Mar 2008, 16(3):585-591.
9. Berry D.C., Noy N. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor. Mol Cell Biol Jun 2009, 29(12):3286-3296.
10. Mukherjee R., Davies P.J., Crombie D.L., Bischoff E.D., Cesario R.M., Jow L., et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature Mar 27 1997, 386(6623):407-410.
11. Guleria R.S., Choudhary R., Tanaka T., Baker K.M., Pan J. Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system. J Cell Physiol May 2011, 226(5):1292-1307.
12. Singh A.B., Guleria R.S., Nizamutdinova I.T., Baker K.M., Pan J. High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling. J Cell Physiol Aug 31 2011, 227(6):2632-2644.
13. Nizamutdinova I.T., Guleria R.S., Singh A.B., Kendall J.A., Baker K.M., Pan J. Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis via inhibition of sustained activation of NF-kappaB signaling. J Cell Physiol Feb 2013, 228(2):380-392.
14. Purves R.D. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J Pharmacokinet Biopharm Jun 1992, 20(3):211-226.
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia Jul 1985, 28(7):412-419.
16. Singh V.P., Le B., Khode R., Baker K.M., Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes Dec 2008, 57(12):3297-3306.
17. Kramer J.K., Sauer F.D., Wolynetz M.S., Farnworth E.R., Johnston K.M. Effects of dietary saturated fat on erucic acid induced myocardial lipidosis in rats. Lipids Aug 1992, 27(8):619-623.
18. Choudhary R., Palm-Leis A., Scott R.C., Guleria R.S., Rachut E., Baker K.M., et al. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am J Physiol Heart Circ Physiol Feb 2008, 294(2):H633-H644.
19. Fulop N., Mason M.M., Dutta K., Wang P., Davidoff A.J., Marchase R.B., et al. Impact of type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am J Physiol Cell Physiol Apr 2007, 292(4):C1370-C1378.
20. Toblli J., Cao G., Rivas C., Munoz M., Giani J., Dominici F., et al. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens May 2010, 28(5):1007-1019.
21. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature Apr 13 2000, 404(6779):787-790.
22. Thandavarayan R.A., Watanabe K., Ma M., Gurusamy N., Veeraveedu P.T., Konishi T., et al. Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus. Am J Physiol Heart Circ Physiol Sep 2009, 297(3):H911-H919.
23. Tsai K.H., Wang W.J., Lin C.W., Pai P., Lai T.Y., Tsai C.Y., et al. NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-kappaB in cardiomyocytes exposed to high glucose. J Cell Physiol Apr 2012, 227(4):1347-1357.
24. Tschope C., Walther T., Escher F., Spillmann F., Du J., Altmann C., et al. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J Dec 2005, 19(14):2057-2059.
25. Lorenzo O., Picatoste B., Ares-Carrasco S., Ramirez E., Egido J., Tunon J. Potential role of nuclear factor kappaB in diabetic cardiomyopathy. Mediators Inflamm 2011, 652097.
26. Asbun J., Villarreal F.J. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol Feb 21 2006, 47(4):693-700.
27. Petrov V.V., Fagard R.H., Lijnen P.J. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension Feb 2002, 39(2):258-263.
28. Molotkov A., Duester G. Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid. J Biol Chem Sep 19 2003, 278(38):36085-36090.
29. Duester G. Genetic dissection of retinoid dehydrogenases. Chem Biol Interact Jan 30 2001, 130-132(1-3):469-480.
30. Parekh N., Maisel A.S. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. Curr Opin Cardiol Mar 2009, 24(2):155-160.
31. van den Hurk K., Alssema M., Kamp O., Henry R.M., Stehouwer C.D., Diamant M., et al. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. Eur J Heart Fail Sep 2010, 12(9):958-965.
32. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125(1):188-197.
33. Stanley W.C., Lopaschuk G.D., McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res Apr 1997, 34(1):25-33.
34. Basu R., Oudit G.Y., Wang X., Zhang L., Ussher J.R., Lopaschuk G.D., et al. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol Dec 2009, 297(6):H2096-H2108.
35. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes Jun 2002, 51(6):1938-1948.
36. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res Oct 29 2010, 107(9):1058-1070.
37. Lim H.S., MacFadyen R.J., Lip G.Y. Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. Arch Intern Med Sep 13 2004, 164(16):1737-1748.
38. Bugger H., Riehle C., Jaishy B., Wende A.R., Tuinei J., Chen D., et al. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J Mol Cell Cardiol May 2012, 52(5):1019-1026.
39. Maisch B., Alter P., Pankuweit S. Diabetic cardiomyopathy-fact or fiction?. Herz Mar 2011, 36(2):102-115.
40. Falcao-Pires I., Leite-Moreira A.F. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev May 2012, 17(3):325-344.
41. Daniels A., Linz D., van Bilsen M., Rutten H., Sadowski T., Ruf S., et al. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats. Eur J Heart Fail Feb 2012, 14(2):193-201.
42. Baynes J., Murray D.B. Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats. Oxid Med Cell Longev Nov-Dec 2009, 2(5):328-334.